v3.25.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 39,711,409 $ 45,816,289
Investments 14,841,251 14,395,913
Other current assets 523,556 78,869
Total current assets 55,076,216 60,291,071
Operating lease right-of-use asset 9,102 0
Total assets 55,085,318 60,291,071
Current liabilities:    
In-process R and D accrued expenses 0 3,000,000
Accounts payable, accrued expenses and other current liabilities 1,491,960 2,254,300
Total current liabilities and total liabilities 1,491,960 5,254,300
Commitments and contingencies (Note 9)
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 6,115,214 and 6,102,560 shares issued and outstanding at March 31, 2025, and December 31, 2024, respectively** [1] 6,115 6,103
Additional paid-in capital 132,026,635 130,787,312
Accumulated other comprehensive (loss) income (21,784) 35,992
Accumulated deficit (78,417,608) (75,792,636)
Total stockholders’ equity 53,593,358 55,036,771
Total liabilities and stockholders’ equity $ 55,085,318 $ 60,291,071
[1] Information pertaining to number of shares outstanding and per share data gives retroactive effect to a 1 for 5 reverse stock split that became effective on August 12, 2024.